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Abstract
Fatal human respiratory disease associated with the 1918 pandemic influenza virus and potentially pandemic H5N1 viruses
is characterized by severe lung pathology, including pulmonary edema and extensive inflammatory infiltrate. Here, we
quantified the cellular immune response to infection in the mouse lung by flow cytometry and demonstrate that mice
infected with highly pathogenic (HP) H1N1 and H5N1 influenza viruses exhibit significantly high numbers of macrophages
and neutrophils in the lungs compared to mice infected with low pathogenic (LP) viruses. Mice infected with the 1918
pandemic virus and a recent H5N1 human isolate show considerable similarities in overall lung cellularity, lung immune cell
sub-population composition and cellular immune temporal dynamics. Interestingly, while these similarities were observed,
the HP H5N1 virus consistently elicited significantly higher levels of pro-inflammatory cytokines in whole lungs and primary
human macrophages, revealing a potentially critical difference in the pathogenesis of H5N1 infections. These results
together show that infection with HP influenza viruses such as H5N1 and the 1918 pandemic virus leads to a rapid cell
recruitment of macrophages and neutrophils into the lungs, suggesting that these cells play a role in acute lung
inflammation associated with HP influenza virus infection. In addition, primary macrophages and dendritic cells were also
susceptible to 1918 and H5N1 influenza virus infection in vitro and in infected mouse lung tissue.
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Introduction
The influenza pandemic from 1918 to 1919 was the most
devastating infectious disease pandemic ever documented in such
a short period of time, killing nearly 50 million people worldwide
[1]. Unlike the epidemiological profiles of most influenza
infections, young adults aged 18–35 yrs old had the highest
mortality rate, so much so that the average life expectancy during
those years was lowered by 10 years [2]. In 1918, severe
destruction of lung tissue observed by pathologists at autopsy
was unlike that typically seen in cases of pneumonia [3] and
histopathological analysis of lung tissue showed severe tissue
consolidation with unique destruction of the lung architecture
[3,4]. Human infections with highly pathogenic avian influenza
(HPAI) strains of subtype H5N1 since the first outbreak in 1997
have also been particularly severe for children and young adults
[5–7]. Assessing pulmonary infiltrates in response to influenza
H5N1 virus infection has been difficult due to the lack of autopsy
material. The basis for the high morbidity and mortality associated
with the 1918 virus and recent H5N1 viruses remains inconclusive
based on viral genetic analysis alone and accounts of patient lung
pathology provide only qualitative information about the host
factors contributing to disease [4,8,9]. Great concern about a
pandemic caused by a novel avian H5 subtype virus warrants
comparative studies to better understand the cellular pathology
caused by a pandemic virus and potentially pandemic viruses.
Identification and quantification of the inflammatory cell types
associated with highly pathogenic respiratory infections represent
prospective targets for modulation of host innate immune
responses.
Recent studies using animal models to investigate the
mechanism(s) of severe influenza virulence have implicated the
innate immune system in complicating lung tissue recovery [10–
13]. Mouse models of highly pathogenic (HP) H5N1 [14–18]
and 1918 [19,20] influenza virus infection confirm histological
observations of severe lung pathology in human patients,
however, the types of immune cells present during the peak of
lung pathology have not been fully elucidated. Excessive immune
cell infiltration during an acute lung injury may impair tissue
restoration directly by interfering with gas exchange, or
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the present study, we determined key immune cellular compo-
nents in the murine lung following infection with matched H5N1
and H1N1 virus pairs that represent high and low virulence
infections of each influenza subtype as previously determined in
the mouse model [18,21]. The two H5N1 viruses used in this
study (A/Thailand/16/2004 and A/Thailand/SP/83/2004)
were isolated in 2004 from fatal human cases in Thailand but
have a differential pathogenic outcome in mice, specifically a low
and high mouse lethal does 50 (LD50=1.7 and 5.6 log 10 PFU
respectively) [18]. For relevant comparison, we also used a
contemporary (non lethal) seasonal H1N1 human isolate from
1991 (A/TX/36/91) and the reconstructed 1918 pandemic virus
[21]. A detailed flow cytometry evaluation of lung cells
demonstrated that macrophages and neutrophils are the
prominent cell types associated with and potentially mediating
the severe lung pathology following infection with the highly
virulent H5N1 and 1918 viruses. Moreover, inoculation of
macrophages and dendritic cells with the HP viruses in vitro or ex
vivo reveals that some innate immune cells can themselves serve
as targets of viral infection.
Results
Highly pathogenic H1N1 and H5N1 viruses exhibit early
and sustained replication in murine lung tissue following
intranasal infection
Female BALB/c mice were infected intranasally with either
highly pathogenic (HP) or low-pathogenic (LP) influenza viruses
(Table 1, Methods) based on known LD50’s and phenotypes of
disease in mouse [21] and ferret [18,22] models. As shown in
Figure 1, the 1918 (H1N1) and A/Thailand/16/2004 (Thai/16,
H5N1) viruses replicated to high titers that were at least 5-fold
higher than the respective LP viruses, A/Texas/36/91 (TX/91,
H1N1) and A/Thailand/SP/83/2004 (SP/83, H5N1) as early as
1 day post-infection (p.i.) and sustained higher levels of replication
than the LP viruses throughout the course of infection. 1918 and
TX/91 virus infected lungs reached peak titers on day 3 p.i. and
remained elevated for the duration of the study. The HP Thai/16
virus reached peak titers later than the 1918 virus at day 5 pi.
while the less mouse-virulent SP/83 virus reached it’s highest titers
on day 7 p.i.. Lung virus titers were significantly higher (*p,0.05)
in the 1918 and Thai/16 virus groups compared to TX/91 and
SP/83 infected mice at all time points measured.
Increased cellularity in lungs of mice infected with highly
pathogenic H1N1 and H5N1 influenza viruses
Whole lungs collected (without perfusion, therefore including
the bronchoalveolar lavage contents (BAL)) from both 1918 and
Thai/16 virus-infected mice showed an increase in overall tissue
cellularity as early as 3 days p.i. (Figure 2A). By day 3 p.i., lungs
infected with the HP influenza viruses (containing between 4.3–
5.1610
7 cells) had nearly twice as many total lung cells than were
measured in the HP infection groups just 24 hours previously at
day 2 p.i. (2.1–2.4610
7 cells). Significant differences (*p,0.05)
were observed between HP and LP infection groups in total lung
cell number at every time after day 2 p.i. Total lung cell numbers
doubled in HP infection groups between days 5 and 7 p.i. and by
day 7 p.i., when viral titers were high for all four viruses, total cell
numbers in the lungs of mice infected with either HP H1N1 or
H5N1 viruses were 6-fold higher than those in PBS-inoculated
mice, and at least 3-fold higher than those found in LP virus-
infected lungs (Figures 1 and 2A). On day 7 p.i., there were as
many as 1.3610
8 cells in HP-infected lungs compared with 4.0–
8.0610
7 cells in LP-infected and 1.8610
7 cells in PBS- inoculated
lungs.
To quantify the immune cell sub-populations responding to
viral infection, we next determined the total cell numbers of
specific inflammatory cell populations in the infected lungs using
flow cytometry (Figure 2B). Compared with PBS- inoculated
Author Summary
Patients who succumbed to influenza during the 1918
pandemic had severe lung pathology marked by extensive
inflammatory infiltrate, indicating a robust immune
response in the lung. Similar findings have been reported
from H5N1-infected patients, raising the question as to
why people expire in the presence of a strong immune
response. We addressed this question by characterizing
the immune cell populations in the mouse lung following
infection with the 1918 pandemic virus and two H5N1
viruses isolated from fatal cases. Our data shows excessive
immune cell infiltration in the lungs contributing to severe
consolidation and tissue architecture destruction in mice
infected with highly pathogenic (HP) influenza viruses,
supporting the histopathological observations of lung
tissue from 1918 and H5N1 fatalities. We found that certain
cells of the innate immune system, specifically macro-
phages and neutrophils, increase significantly into the
mouse lung shortly following HP virus infection. Interest-
ingly, lung macrophages and dendritic cells were shown to
be susceptible to 1918 and H5N1 virus infection in vitro or
ex vivo, suggesting a possible mechanism of immuno-
pathogenesis. Identification of the precise inflammatory
cells associated with lung inflammation will be important
for the development of treatments that could potentially
enhance or modulate host innate immune responses.
Table 1. Viruses used in this study.
Virus
{ Subtype Source MLD*50
{ Ferret pathotype
{
A/Texas/36/91 H1N1 Non fatal case NL Low virulence
A/1918 H1N1 rg
^ 3.2 High virulence
A/Thailand/SP/83/2004 H5N1 Fatal case, 58 yrs old 5.5 Low virulence
A/Thailand/16/2004 H5N1 Fatal case, 7 yrs old 1.7 High virulence
{Abbreviations used in the text: TX/91, 1918, SP/83, Thai/16
*Fifty-percent mouse lethal dose (log10) titers.
{NL=Not mouse lethal [18,21,22].
^Generated by reverse genetics [21].
doi:10.1371/journal.ppat.1000115.t001
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increase in the numbers of macrophages (CD11b
+, CD11c
2,
Ly6G/c
2, CD4
2, CD8
2) beginning 3 days p.i. and continuing
through day 9 p.i. Strikingly, there were significantly (*p,0.05)
more macrophages in HP virus-infected lungs than in LP virus-
infected lungs from days 2 through 9 p.i. (Figure 2B, a). As early as
2 days p.i, there was 1–2 million more macrophages in the lungs of
HP-infected lungs compared to LP infected lungs. 1918 and Thai/
16 virus–infected lungs had twice as many and nearly 4 times as
many macrophages compared to LP viruses at days 3 and 5,
respectively. Numbers of lung macrophages peaked in 1918 and
Thai/16 infected mice (1.5 and 1.2610
7 cells, respectively) at day
7 p.i. before waning as demonstrated at day 9 p.i.
An increase of at least twice as many neutrophils (CD11b
+,
CD11c
2, Ly6G/c
+, CD4
2, CD8-) was observed as early as 1 day
p.i. in all infection groups, compared with neutrophils numbers in
PBS-inoculated mice. On day 2 p.i. there was on average (n=3
mice) over four hundred thousand more neutrophils in the lungs
of 1918 virus inoculated mice than TX/91 inoculated mice.
Significant differences in neutrophil populations (*p,0.05)
between the HP and the LP virus groups emerged on day 3 p.i.
and were sustained at each subsequent time point measured
(Figure 2B, b). On day 3 p.i., more than twice as many neutrophils
were found in HP compared to LP infected lungs. Between days 3
and 7 p.i., lungs infected with HP viruses displayed a three fold
increase in neutrophil numbers. At the peak of neutrophil
infiltration on day 7 p.i, there was 4–8 million more neutrophils
in the lungs of HP-infected animals compared to LP virus-infected
mice. Although numbers of dendritic cells (CD11b
2, CD11c
+,
Ly6G/c
2, CD4
2 , CD8
2) (Figure 2B, c) and CD4
+ T (CD11b
2,
CD11c
+, Ly6G/c
2, CD8
2) and CD8
+ T (CD11b
2, CD11c
+,
Ly6G/c
2, CD4
2) cells (Figure 2B, d and e) in all groups of
infected mice increased slightly compared with numbers in PBS-
inoculated animals during the course of infection, no significant
differences were found between HP and LP infection groups,
suggesting that these cell populations are not major contributors to
the histopathological consolidation observed in lungs during HP
H5N1 virus infections in mice [16].
Macrophages and neutrophils account for the highest
percentage of the total lung leukocytes following
infection with highly pathogenic influenza viruses
We next determined specific immune cell sub-populations given
by percent of the total lung leukocyte population in order to reveal
differential population dynamics amongst the immune cell
populations measured in these studies (Table 2). Strikingly,
macrophage populations by day 3 pi, represented 24% and
24.4% (nearly one-quarter) of the total gated lung leukocytes of
mice infected with 1918 and Thai/16 (HP) viruses, respectively,
which was significantly higher than the frequency of macrophages
detected in TX/91 and SP/83 virus-infected mice from days 2
though 9 p.i. (^ p,0.005). Neutrophil populations were elevated in
all infection groups compared to mock levels beginning 1 day p.i
(Figure 2, panel B) however percentages of neutrophils in HP virus
infected mice were significantly higher (* p,0.05) than those in LP
virus-infected mice beginning day 2 p.i. and levels remained
elevated at each subsequent time point measured (Table 2).
In contrast, dendritic cell populations as percent of the total
leukocyte population declined over the course of infection with HP
viruses while percentages increased in LP infections, peaking at days
3and 5p.i.(Table 2).Significant differencesinpercentdendriticcells
between HPand LPinfection groups wereobserved day 3 p.i. and at
all other subsequent time points (* p,0.05). Percentages of CD4
+ T
cells in the lungs decreased in all infection groups but no significant
differences were observed in CD4
+ or CD8
+ T cell population
dynamics between HP and LP infection groups. Together, these
results indicate that macrophages and neutrophils areresponsible for
the majority increase in total lung cell numbers following infection
with the 1918 and HP H5N1 influenza viruses.
The 1918 pandemic virus and a highly pathogenic H5N1
virus elicit significantly high levels of pro-inflammatory
cytokines in the lung
To better understand potential influences on immune cell
population dynamics in the lung following HP influenza virus
infection as demonstrated in Figure 2B and Table 2, we analyzed
17 chemokines and cytokines in the lungs of mice on days 1 and 4
p.i and report data here on 6 of the analytes that revealed
significant differences among the viruses tested (Figure 3). These
earlier time points were chosen in an effort to understand the
temporal relationship with lung immune cell infiltration in 1918
and Thai/16 infections (Figure 2) and day 4 p.i. is a time when
significant differences were observed in lung virus titers between
HP and LP infection groups (Figure 1). As shown in Figure 3, on
day 1 p.i. TX/91 infected lungs exhibited higher titers of IL-1a,
IFN-c, and KC compared to 1918 virus-infected lungs though
levels of MIP-1a, MCP-1, and IL-6 were higher in 1918 virus
infected lungs. Cytokine levels were similar between the H5N1
viruses at day 1 p.i.. In contrast, lung tissue cytokine and
chemokine levels at day 4 p.i. were higher among 1918 and Thai/
16 virus-infected mice compared to those infected with the
subtype-matched LP (TX/91 and SP/83) counterpart viruses for
all cytokines and chemokines measured. Protein levels of the
potent monocyte chemoattractant MCP-1 were 10-fold higher in
1918 and H5N1 virus-infected lungs than TX/91 virus-infected
lungs, whereas levels of the MIP-1a chemokine were notably
elevated in Thai/16 virus-infected lungs. KC (the mouse
equivalent of human IL-8) [20,23] levels were 10-fold higher in
Thai/16 and 3-fold higher in 1918 virus infected lungs compared
to TX/91 virus-infected lungs with SP/83 levels similar to 1918
infected lungs. The HP viruses were also potent inducers of IL-1a
and IFNc. IL-6, (a generally pro-inflammatory cytokine) was also
Figure 1. Lung virus titers. Female BALB/c mice were infected
intranasally with 10
2 PFU of influenza viruses and lungs were harvested
for virus titration at various times post-inoculation. Lungs were
homogenized in 1 ml of PBS and virus titers determined by plaque
assay (+ TPCK trypsin 1 mg/ml) on MDCK cells in duplicate (n=3 mice
per time point). * p,0.05 between 1918 and Thai/16 infected lungs and
TX/91 and SP/83 infected lungs.
doi:10.1371/journal.ppat.1000115.g001
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TX/91 levels. As shown in Figure 3, significant differences
(^ p,0.05) were measured between 1918 and TX/91 virus
infected lungs on day 4 p.i. for each cytokine and chemokine,
accentuating important immunological differences in the
immune response to the H1N1 pandemic virus versus a
contemporary H1N1 virus.
Innate immune cells are targets of highly pathogenic
influenza virus infection
Due to the increased presence of macrophages in the lungs
following HP influenza virus infection, replication of paired H1N1
and H5N1 viruses (Table 1) was assayed over time in primary
human PBMC-derived macrophages and mouse lung macrophag-
es to address whether these cells are specific targets of viral
Figure 2. Lung cell characterization following infection with highly pathogenic influenza viruses. (A) Total viable lung cell numbers
post-infection. Mice were infected with 10
2 PFU of influenza viruses, lungs removed and cell suspensions prepared at various times post-inoculation.
Viable cells were counted on a hemocytometer by trypan blue exclusion. The data shown represents the total number of viable lung cells from three
mice per time point, (per virus group) and standard deviations from the mean cell numbers (610
7 cells) are shown as error bars, * p,0.05. (B) Lung
immune cell sub-populations. Mean lung immune cell sub-populations (as determined by appropriate gating on labeled cells) are representative of 3
mouse lungs per time point/per virus group and standard deviations are shown in parentheses where available. Numbers of macrophages (CD11b
+,
CD11c
2, Ly6G/c
2)(a), neutrophils (CD11b
+, CD11c
2, Ly6G/c
+) (b), and dendritic cells (CD11b
2, CD11c
+, Ly6G/c
2) (c) were determined by appropriate
gating within the total lung leukocytes. T cell numbers (d and e) were determined by gating within the lymphocyte gate of the total leukocyte
population gate. ^ On days 1, 2 and 12 p.i (CD 4
+) and CD8
+ cells (all time points) are presented as averages of 3 lungs.
doi:10.1371/journal.ppat.1000115.g002
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macrophages were harvested from naive BALB/c mice and
infected in vitro (MOI=0.1, Figure 4A) as described. While the HP
1918 and Thai/16 viruses exhibited a slight increase in log titer
very early after inoculation (13–24 hrs p.i.), overall these viruses
did not replicate efficiently compared to the growth kinetics of
these viruses observed in lung epithelial cells [22,24]. At 13 hrs p.i.
there was 18 fold higher 1918 and Thai/16 virus released from
infected cells than TX/91 and SP/83 virus-inoculated cultures
and nearly 54 times more 1918 and Thai/16 virus than TX/91 or
SP/83 virus at 24 hrs p.i. While virus titers in the 1918, TX/91
and SP/83 infection groups declined after the 48 hr time point,
the Thai/16 infected macrophages maintained virus titers and
these differences were statistically significant (^ p,0.05) at 72 hrs
p.i.. The lack of prolific replication of these four viruses in primary
mouse lung macrophages was confirmed further when a higher
MOI (1.0) was utilized (data not shown). Human macrophages
also supported replication of all four viruses (Figure 4B,
MOI=0.1). At 48 hrs p.i. 1918 and Thai/16 infected macro-
phages exhibited 180 times higher virus titers than TX/91 and
SP/83 infected cultures. Interestingly, 1918 virus-infected macro-
phages exhibited a higher baseline titer soon following infection
that was found to be statistically significant when compared to the
other infection groups (
{ p,0.05). In summary, while human
macrophages are a target of viral replication and support
replication well, mouse lung macrophages support low levels of
1918 and Thai/16 virus production early following infection.
Additional experimentation with primary human macrophages
revealed that levels of pro-inflammatory cytokines were higher for
H5N1-infected cells than either 1918 or TX/91 virus infected cells
(48 hrs p.i., MOI=0.1, Figure 5). Significant differences in
cytokine levels were observed between H5N1 and H1N1 virus
Table 2. Mouse lung immune cell population dynamics during influenza virus infection.
Group Mean % Total Gated Leukocytes (SD
{)
Days post-infection
1 2 3 5791 2
1918 5.6 (0.8) 9.9 (1.4)
^ 24.0 (4.7) * ^ 6 23.1 (1.2)* ^ 6 25.6 (1.6)* ^ 6 21.0 (1.4)* ^ 6
TX/91 5.6 (0.2) 6.0 (1.0) 13.7 (5.0) 9.4 (0.9) 8.1 (0.4) 12.6 (1.8) NA
{ Macrophages (CD11b+, CD11c2, Ly6G/C2, CD42,
CD82)
SP/83 4.6 (0.9) 6.6 (1.6) 14.1 (2.8) 11.1 (1.3) 10.9 (0.3) 9.5 (1.1)
Thai/16 4.7 (0.7) 10.2 (1.8) 24.4 (6.2) 23.3 (5.3) 22.9 (4.0) 25.2 (0.0)
PBS 4.9 (0.3)
1918 7.7 (1.0) 11.9 (0.2)* ^ 11.4 (3.1)* ^ 10.1 (0.5)*
^ 12.8 (1.1)* ^ 6 10.1 (3.9)* ^ 6
TX/91 6.9 (0.4) 7.8 (0.3) 6.1 (0.6) 5.5 (0.7) 5.7 (0.5) 5.6 (0.6) NA Neutrophils (CD11b+, CD11c2, Ly6G/C+, CD42, CD82)
SP/83 7.7 (0.5) 7.5 (2.5) 6.3 (1.5) 7.8 (4.5) 8.4 (5.9) 8.7 (0.8)
Thai/16 9.7 (1.1) 8.9 (0.8) 9.3 (3.0) 9.1 (1.3) 15.2 (1.6) 18.8 (0.0)
PBS 5.3 (0.8)
1918 3.0 (0.3) 2.5 (0.3) 3.0 (0.4)* 2.3 (0.3)* 2.2 (0.1)* 1.9 (0.2)*
TX/91 3.5 (1.2) 3.4 (0.5) 4.7 (0.4) 5.7 (1.0) 3.4 (0.6) 3.7 (0.5) NA Dendritic cells (CD11b2, CD11c+, Ly6G/C2, CD42,
CD82)
SP/83 3.7 (0.8) 4.1 (1.0) 6.2 (1.7) 4.4 (0.4) 3.7 (0.6) 3.6 (0.6)
Thai/16 3.2 (0.1) 4.0 (0.4) 4.6 (1.3) 3.4 (0.6) 2.5 (0.4) 2.0 (0.0)
PBS 3.8 ( 0.2)
1918 13.4 12.1 5.7 (2.5) 8.3 (0.8) 4.9 (2.7) 10.6 (2.7) 7.2
TX/91 11.4 9.2 4.0 6.7 (0.1) 2.5 (0.1) 8.6 (0.6) 2.2 CD4+ T cells (CD4+, CD82, CD11b2, CD11c2, Ly6G/C2)
SP/83 10.0 14.6 4.9 (3.2) 8.0 (1.6) 3.0 (0.7) 9.6 (1.2) 3.1
Thai/16 10.2 14.1 3.7 (1.0) 5.2 (0.8) 0.7 (0.3) 4.8 3.9
PBS 7.2 (2.2)
1918 3.9 5.4 1.8 4.5 2.6 6.8 4.8
TX/91 2.1 1.1 2.9 4.3 2.5 1.0 0.8 CD8+ T cells (CD42, CD8+, CD11b2, CD11c2, Ly6G/C2)
SP/83 2.3 1.4 2.3 2.2 1.8 5.9 1.5
Thai/16 2.2 2.8 2.7 3.0 1.7 1.3 1.6
PBS 2.0
BALB/c mice were infected intra-nasally with 102 PFU influenza viruses (Table 1). Lung immune cell populations were analyzed by flow cytometry from single cell
suspensions from three mice per time point, per virus group.
{Numbers of immune cell sub-populations are represented here as percent of the total leukocytes measured in these assays. Standard deviations are shown in
parenthesis where available. PBS group % populations represented are daily averages.
*p,0.05 between HP (1918, Thai/16) and LP (TX/91,SP/83) infection groups.
^p,0.05 between 1918 and TX/91 infection groups.
6p,0.05 between Thai/16 and SP/83 infection groups.
{Not analyzed.
doi:10.1371/journal.ppat.1000115.t002
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IL-8 where all four viruses elicited similar levels of this chemokine.
Interestingly, the 1918 virus elicited similar cytokine responses as
to TX/91 inoculated cells in every cytokine measured even though
1918 virus titers at this time point post-infection were 2.5 logs
greater than TX/91 infected macrophages (Figure 4B). Thai/16
infected cultures elicited at least a 2 fold greater cytokine response
than the SP/83 virus infected cultures in every cytokine measured
except IL-8 and MCP-1 chemokines where Thai/16 levels were
only slightly higher than SP/83 levels.
Because of their important role in antigen presentation to T
cells, we also assessed the ability of primary dendritic cells to
productively replicate pandemic H1N1 and human H5N1 viruses
(Figure 6A and B). While the HP Thai/16 H5N1 virus replicated
slowly over time in cultured mouse lung dendritic cells (Figure 6A),
these cells failed to productively replicate 1918, TX/91 and SP/83
viruses. Significant differences in virus titers were measured
between HP (1918 and Tha/16) infected cells and TX/91 and
SP/83 infected cells at 24 hrs p.i. (Figure 6A, ^ p,0.05).
Significant differences in virus titers was also observed between
Thai/16 inoculated cultures and the other infection groups at 48
and 72 hrs p.i. (* p,0.05). Similar to infected human macrophag-
es, these trends were conserved when primary human dendritic
cells were the target of infection with these viruses (Figure 6B).
Significant differences in virus titers was observed between Thai/
16 inoculated cultures and the 1918, TX/91, and SP/83 infection
groups at 24, 48 and 72 hrs p.i. (* p,0.05).
To determine if innate immune cells are being productively
infected in vivo, macrophages and dendritic cells were purified from
lungs of infected mice and cultured for infectious virus. Lungs from
infected (3 days p.i.) mice were harvested and ex vivo cultures
containing either lung macrophages or dendritic cells were
sampled for infectious virus over a 65 hour time period. While
the seasonal influenza isolate, TX/91 virus was not produced from
either macrophages (CD11b+) or dendritic (CD11c+) cells, the
1918 pandemic virus as well as the two human H5N1 isolates were
released into the culture supernatant (Figure 7), indicating that
these cells are being productively infected in the mouse lung. In
CD11b+ (macrophages) cell cultures (Figure 7A), the 1918 and
Thai/16 virus infected cells released more infectious virus over
time than the LP SP/83 virus infected culture. In CD11c+
(dendritic) cell cultures, the Thai/16 virus infected cultures
Figure 3. Lung cytokine response. Cytokine levels from infected lungs (n=3 mice per virus group, days 1 and 4 post-inoculation (p.i.)) were
measured individually and in duplicate by the Bioplex Protein Array system lungs. Baseline cytokine levels from PBS inoculated mice (mock) are
shown as a dashed line in each cytokine graph. Bars represent means of 3 mice from each infection group6standard deviation (SD). Protein levels of
IL-6 in Thai/16 infected animals exceeded the y scale shown (indicated by a dash//, the concentration in Thai/16 infected mice was 11.7 ng/ml).
^ p,0.05 between 1918 and TX/91 viruses, * p,0.05 between 1918 and Thai/16 (HP) virus groups and SP/83 and TX/91 (LP).
doi:10.1371/journal.ppat.1000115.g003
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infected cultures (Figure 7B). These data further demonstrate that
mouse lung macrophages and dendritic cells are susceptible to
highly pathogenic influenza virus infection in the lung tissue.
Discussion
Lung consolidation has been described as a pathological feature
of severe influenza virus infection caused by the 1918 pandemic
virus and H5N1 viruses in humans [9,25,26] as well as in animal
models [11,12,18]. Using a detailed flow cytometry evaluation, the
current study set out to characterize differences in the cellular
innate immune response in the mouse lung following highly
pathogenic (HP) or low pathogenicity (LP) influenza virus
infections. Lungs from mice infected with the HP 1918 H1N1
virus and a recent H5N1 human isolate (A/Thailand/16/04
(Thai/16)) exhibited a significant increase in cellularity in
comparison to the LP seasonal H1N1 isolate, A/Texas/36/91
(TX/91). Significant differences in titer between HP and LP virus-
infected mice were observed as early as day 1 post-inoculation
(p.i.), likely forecasting the dramatic increase in immune cell
infiltration in the lungs of these virus-infected mice. Interestingly at
day 7 p.i. when peak lung cellularity was observed in HP virus
infection groups, differences in virus titers between paired subtype
viruses (1918 compared to TX/91 and Thai/16 compared to SP/
83) were minimal and were limited to a maximum difference of 1
log (Figure 1), indicating a failure by the immune system to clear
the viral infection. Lung cellularity was further investigated by
characterizing the comprising immune cell sub-populations. We
observed a significant increase in macrophages and neutrophils
early following infection with the 1918 and Thai/16 viruses, and
their sustained presence in the lung tissue mark a distinction
between HP and LP influenza virus infection. These data show
that virus replication in the lungs of HP influenza infections are
sustained at high levels the first week of infection regardless of the
high numbers of immune cells present in the tissue. Although the
current study did not determine whether these cells are playing an
antiviral role against the HP viruses, it has been previously shown
that neutrophils and macrophages assist in the clearance of
influenza virus early during infection; these cells appear to be
capable of only partially reducing the virus load in the lung despite
their presence at high numbers [20]. We also observed a decrease
in the percentage of lung–associated dendritic cells and T cell
lymphocytes during HP influenza virus infection. A decrease in the
number of circulating lymphocyte populations has also been
previously observed in the peripheral blood of humans and mice
infected with H5N1 viruses [5,9,10,15,20,27]. The precise
mechanism of leukocyte depletion during H5N1 infections is not
well understood, but evidence of apoptosis in the spleen and lungs
of HP H5N1-infected mice detected in situ suggests a mechanism
for cell loss [16].
Influenza virus growth in the respiratory epithelium and the
subsequent release of chemotactic proteins from those cells may
encourage the increased presence of macrophages and neutrophils
[28,29]. Macrophages and neutrophils can secrete chemokines
and cytokines that can act in an autocrine fashion which in turn
can promote the increased migration of those cells and other
leukocytes into the lung tissue [30]. Elevated levels of certain
chemokines and cytokines have been associated with high viral
load and severe disease in H5N1 virus infected patients [26,31].
These studies show that infection with HP 1918 and Thai/16
H5N1 viruses result in elevated amounts of pro-inflammatory
chemokines and cytokines in the lungs of mice day 4 post-infection
compared with TX/91 and SP/83 infected mice, a time point that
correlates with rising but significantly different lung virus titers
between infection groups. Elevated levels of the chemokines MCP-
1 [32] and MIP1-a were observed among H5N1 and 1918 virus
infected mouse lungs. Although, MIP-1a does not appear to be
critical for virus replication and spread in the mouse model [10],
this chemokine exhibits a variety of pro-inflammatory activities
including macrophage and neutrophil recruitment and has been
associated with fatal outcomes in human H5N1 virus infections
[31]. Lungs infected with the 1918 pandemic and Thai/16 H5N1
viruses also exhibited significantly higher levels of IFN-c on day 4
p.i compared to their subtype-paired LP virus counterparts. IFN-c
is known to mediate the increased production of nitric oxide [33]
which can subsequently result in the recruitment of more
neutrophils and macrophages. Higher levels of IL-6 were
measured in 1918 and Thai/16 virus infected lungs, supporting
observations obtained with the 1997 H5N1 viruses [10] and has
been correlated with systemic illness symptoms and fever in
experimental human TX/91 infections [34]. By directly measur-
ing cytokine protein levels, these data provide confirming evidence
of a heightened lung cytokine response to 1918 and H5N1
infection in mice [13].
Figure 4. Growth of viruses in primary macrophages. Primary
macrophages were harvested from the lungs of healthy BALB/c mice
through tissue digestion (A) and developed from human peripheral
blood monocytes (B) and infected in vitro (MOI=0.1) with influenza
viruses as described (Table 1, Methods). Mouse lung macrophages were
grown in 12 well plates and infected with viruses in duplicate and the
supernatants sampled for virus growth. Human macrophages were
grown in 6 well plates and also infected in duplicate. Virus titers were
determined from supernatants in duplicate by plaque assay on MDCK
cells. Graphs are representative of results obtained from three
independent infection experiments. ^ p,0.05 between Thai/16 and
1918, SP/83 and TX/91 viruses 72 hrs p.i (A). * p,0.05 between HP Thai/
16 and 1918, and LP SP/83 and TX/91 viruses 48 hrs p.i. (B).
{ p,0.05
between the 1918 virus and other viruses 2 hours post- infection (B).
doi:10.1371/journal.ppat.1000115.g004
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HP 1918 and Thai/16 viruses in overall lung cellularity, virus
growth and patterns of immune cell sub-population dynamics over
time, Thai/16 virus infection consistently resulted in higher levels
of chemokines and cytokines both in mouse lungs and human
macrophages. Although it has been shown recently by two
independent research groups that the lack of key cytokines
(through the use of single cytokine gene knockout mice) had no
effect on the overall disease outcome or virus replication among
H5N1 virus-inoculated mice [10,35], the present results along with
data from others continue to indicate that pro-inflammatory
cytokines correlate with disease outcome [36]. It is thought that
these immune mediators do not act singularly in vivo and it will be
critical to reveal these concerted interactions (both locally in the
lung and systemically) to further our understanding of the
pathogenesis of H5N1 infection in animal models and in human
patients.
Macrophages and dendritic cells play a fundamental role in
the lung at all stages of influenza virus infection [20,37,38]. We
have provided evidence regarding the higher replication
efficiency of HP influenza viruses in primary human macro-
phages and dendritic cells, a property that has also been
demonstrated previously in other primary cells [24,39]. Mouse
macrophages were also susceptible to virus infection in vitro,
however they did not support productive replication to the level
observed in primary human monocyte-derived macrophages
(Figure 4B) or lung epithelial cells [21,24]. However, the
cytopathic effects (estimated by visual examination of monolay-
ers) among HP virus-infected mouse and human macrophages
was observed in a shorter period of time compared to LP virus
infected cells. Interestingly, the 1918 virus exhibited higher
baseline titers in human and mouse macrophages as early as
2 hrs p.i. compared to the TX/91 H1N1 virus or the H5N1
viruses, indicating a curious property of this pandemic virus.
While the importance of the binding properties of the HA
molecule has been demonstrated elsewhere extensively
[22,40,41], further resolution of this interesting finding and its
immunological importance deserves further experimentation.
The role of other cell surface molecules on innate immune cells
such as the mannose receptor in HP influenza infection should
be investigated [42,43]. The higher viral replication of HP
viruses in dendritic cells also correlated with the severe
pulmonary disease observed in mice. We also demonstrated
definitively that these cells are targets of infection ex vivo by
highly pathogenic influenza viruses like the 1918 pandemic virus
and recent H5N1 isolates (Figure 7). Thus, it appears that
macrophages and dendritic cells may contribute to the
pathogenesis of HP virus infection due to their susceptibility to
influenza virus infection. An inability to mount an adaptive
immune response due to direct infection of important innate
immune cells such as macrophages and dendritic cells may be a
critical difference in host outcome during influenza virus
Figure 5. Cytokine response from infected human macrophages. Primary macrophages were developed from human peripheral blood
monocytes in 6 well plates and infected in vitro (MOI=0.1) with influenza viruses in duplicate as described (Methods, Table 1). Supernatants were
sampled 48 hours post-infection and cytokines measured by Bioplex Protein Array assay (Methods). Macrophages were also treated with bacterial
lipopolysaccharide (LPS, 100 ng) and Poly I/C (100 ng) to serve as positive inducers. * p,0.05 between H5N1 and H1N1 viruses.
doi:10.1371/journal.ppat.1000115.g005
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depletion in infected mice [17] and human patients [9,31] may
allow for uncontrolled viral replication. While reducing viral
load through anti-viral intervention remains the best treatment
option for H5N1 patients, therapies that moderate immunopa-
thology may help to reduce the high case fatality rate currently
associated with virus infection [45].
Materials and Methods
Viruses and cells
All in vitro and in vivo experiments were performed under the
guidance of the U.S. National Select Agent Program in negative
pressure HEPA-filtered biosafety level laboratory (BSL-3+)
enhanced laboratories and with the use of a battery powered
Racal HEPA-filter respirator and according to Biomedical
Microbiological and Biomedical Laboratory procedures. Influ-
enza viruses used in these experiments included the reconstruct-
ed A/South Carolina/1/18 virus (H1N1) [21], A/Texas/36/91
(H1N1), A/Thailand/16/2004 (H5N1), and A/Thailand/SP/
83/2004 (H5N1). These viruses were chosen as pairs within
subtypes due to their respective fifty percent lethal dose (LD50)
titers in mice and ferrets (Table 1). Low pathogenicity in this
manuscript refers to the non-lethal phenotype of the seasonal
H1N1 TX/91 virus and the low virulence SP/83 H5N1 isolate
[18,21]. The Thai/16 and SP/83 viruses differ from each other
in 13 amino acids in 7 proteins and this sequence comparison
has been published previously [18]. The A/Texas/36/91 and
H5N1 viruses were grown in 10 day old embryonated hen’s eggs
and the 1918 viruses grown in MDCK cells. All virus stocks were
titered by plaque assay on MDCK cells prior to mouse
infections.
Human peripheral blood monocytes (PBMC’s) were obtained
by Histopaque (Sigma-Aldrich, St. Louis, MO) density gradient
centrifugation of whole blood donated by healthy donors aged
20–40 yrs old without history of influenza vaccination in the past
year. Whole blood was obtained through an approved protocol
by both the Emory University Institutional Review Board (IRB)
and CDC IRB (Emory University Hospital Blood Bank is an
FDA-accredited Blood Bank). Human monocytes were obtained
by negative selection column enrichment (Miltenyi Biotech,
Auburn, CA) yielding approximately 90% CD14+ purity as
determined by FACS analysis. For development of macrophages,
monocytes were cultured at 37uC in 6 well plates in Macrophage
SFM media (Gibco, Grand Island, NY) with 20% heat
inactivated autologous serum for 7 days in the presence of
GM-CSF (1000 U) before infection [46]. Human macrophages
cultured in this manner typically displayed classical morphology
with the phenotype: CD11b
low,C D 1 1 c
low,H L A - D R
low,
CD14
low,C D 4 0
low,C D 8 0
low,C D 8 3
low, CD86- (Figure 4C and
D). For the development of dendritic cells (DC’s), monocytes
were grown in RPMI (Gibco) with 20% heat inactivated
autologous serum for 10 days in the presence of IL-4 (1000U)
as previously described [46]. Dendritic cells developed in this
manner typically displayed a classical morphology with the
Figure 6. Growth of viruses in primary dendritic cells. Primary
dendritic cells were isolated from the lungs of healthy BALB/c mice and
developed from human monocytes as described in Methods and
infected in vitro with LP and HP influenza viruses (Table 1). Growth of
H5N1 and H1N1 viruses in mouse lung macrophages (A, MOI=0.1) and
in human monocyte-derived dendritic cells (B, MOI=1.0). (^ p,0.05
between HP Thai/16 and 1918 viruses and LP SP/83 and TX/91 viruses.
* p,0.05 between Thai/16 and 1918, SP/83 and TX/91 viruses.) Graphs
are representative of results obtained from three independent
experiments.
doi:10.1371/journal.ppat.1000115.g006
Figure 7. Virus replication from primary lung macrophages and
dendritic cells cultured ex vivo. BALB/c mice were infected
intranasally with 10
2 PFU of the indicated viruses. Three days post-
inoculation, lungs were removed from 2–3 mice per virus group. Cell
suspensions were prepared from pooled samples and macrophages (A)
and dendritic cells (B) were isolated by CD11b+ ad CD11c+ MACS
column purification, respectively. Supernatants from cultures were
sampled over time to measure virus production. Virus was titered in
duplicate by plaque assay.
doi:10.1371/journal.ppat.1000115.g007
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low,
CD11c
high,H L A - D R
high,C D 1 4
low,C D 4 0
high,C D 8 0
high,
CD83
high,C D 8 6
high (Figure 6B).
To obtain primary mouse lung macrophages and dendritic cells,
lungs from naı ¨ve mice were removed and tissue disrupted as
described above through the use of collagenase digestion and cell
suspensions prepared. Macrophages (CD11b+) and dendritic cells
(CD11c+) were extracted from contaminating cells by selection on
magnetic columns (Miltenyi Biotech, Auburn, CA). Cells were
washed twice with media containing 20% FCS (Macrophage SFM
for macrophages (Gibco) or RPMI (Gibco) for dendritic cells) and
cultured for 24 hours before in vitro infection. Primary mouse
lung macrophages typically displayed the phenotype: CD11b
high,
CD11c-, MHCII
high, CD40
high, CD80
high, CD83
high (Figure 4A
and B). Primary mouse lung dendritic cells typically displayed
typical morphology with dendritic extensions and the phenotype:
CD11b-, CD11c
high, MHCII
high, CD40
high, CD80
high, CD83
high
(Figure 6A).
In vitro infections
Primary human and mouse cells were washed 36with serum
free growth media and infected for 1 hour with viruses (Table 1)
at a multiplicity of infection (MOI) of 0.1. Following infection,
cells were washed 36 with serum free growth media and 1 ml
SFM media, containing 1 mg/ml of TPCK-treated trypsin
(Sigma-Aldrich), was placed into the wells. Virus growth was
measured over time in triplicate wells for each experiment and
titered in duplicate by standard plaque assay on MDCK cells. All
macrophage and dendritic cell data reflects at least three
independent experiments (Figures 4 and 6). Cytokine levels
produced from infected human macrophages (MOI=0.1) were
quantitated 48 hrs p.i. by BioPlex assay (Figure 5). Escherichia
coli lipopolysaccharide (LPS, 100 ng, Sigma-Aldrich) and Poly
I/C (100 ng, Sigma-Aldrich) were used as positive control
stimulants.
Mice infections
All animal research was conducted under the guidance of
CDC’s Institutional Animal Care and Use Committee and in an
Association for Assessment and Accreditation of Laboratory
Animal Care International- accredited facility. 8–10 week old
female BALB/c mice (Harlan, Indianapolis, IN) were anesthetized
with Avertin [20] (Sigma-Aldrich) and infected intranasally (i.n.)
with 50 mlo f1 0
2 PFU of influenza viruses prepared in phosphate
buffered saline (PBS). Avertin was chosen as the anesthetic because
it provides consistent mouse infections with the viruses used in
these studies. Using the sublethal (10
2 PFU) inoculum, 1918 and
Thai/16 virus infected mice survive a prolonged disease course
allowing for the measurement of the influx of inflammatory cells
into the lung tissue during a full course (,7–9 days) of influenza
virus infection. At indicated times post-infection (n=3 mice per
virus group) mice were euthanatized and exsanguinated. Lungs
were removed from individual mice without PBS perfusion and
included total lung cell counts included cells located in the
bronchoalveolar airways. Perfusion was not possible in many cases
of HP influenza virus infection due to the presence of
microvascular hemorrhage. We obtained similar results when
performing these lung cell quantitation assays with or without lung
perfusion in LP virus infected mice and therefore did not introduce
this variable in our high containment laboratory. Whole lung cell
suspensions were prepared in Dulbecco’s minimal essential media
(DMEM) with 20% fetal calf serum following collagenase-DNase
treatment and manual disruption [47]. Red blood cells were
removed by lysis buffer treatment (Sigma-Aldrich). Total viable
lung cell number was determined for each mouse by trypan blue
exclusion on a hemocytometer.
For the ex vivo experiment, macrophages and dendritic cells were
isolated from the lungs of infected BALB/c mice. Two or three
mice were infected i.n. with 10
2 PFU of each of the four viruses
described in this study (Table 1). Three days post-inoculation,
lungs were removed without perfusion and cell suspensions were
prepared as described above. Lungs were pooled from mice in
each virus infection group. Macrophages and dendritic cells were
isolated by positive selection on CD11b+ or CD11c+ MACS
columns. Columns containing bound immune cells were washed
extensively (5x) and CD11b+ or CD11c+ cells were eluted off the
magnetic columns and cultured in 6-well plates in 5 ml of RPMI
containing 5% BSA. Supernatants were collected at the indicated
times and virus content was determined in a standard plaque assay
on MDCK cells.
Flow cytometry and lung immune cell quantitation
Lung cell suspensions were incubated with anti-Fc block (anti-
mouse CD16/CD32) to reduce non-specific antibody binding for
10 min. prior to staining for 1 hr with fluorophore-conjugated
antibodies (BD Biosciences, San Diego, CA) specific for immune
cell populations according to standard protocols [48] and
included: CD11b-PE (pan-macrophage), CD11c-APC (pan-den-
dritic cell), Ly6G/C-FITC (neutrophil), CD4-PE and CD8-APC T
cell markers (Table 2, Figure 2). Cells were washed twice with PBS
and fixed overnight at 4uC with 2% paraformaldehyde. Samples
were safety tested for infectious virus and removed from the
BSL3+ laboratory. Flow cytometry was performed on a FACSAria
flow cytometer (BD Biosciences). To further characterize primary
mouse and human macrophage and dendritic cells we utilized the
following fluorescently conjugated antibodies for flow cytometric
analysis: MHC II (I-A/I-E)-PE, HLA-DR-PE, CD14-FITC,
CD40-FITC, CD80-FITC, CD83-APC, and CD86-APC (BD
Biosciences) (Figures 4 and 6).
Virus titrations and cytokine analysis
At various times post-infection (n=3 mice per virus group)
lungs were removed and stored at 270uCu n t i lv i r u sa n d
cytokine levels could be quantified. Lungs were homogenized
individually in 1 ml PBS. Virus was titered from clarified lung
homogenates by standard plaque assay on MDCK cells in
duplicate and titers are reported as plaque forming units per ml
PBS (PFU/ml, Figure 1). Cytokine protein levels were measured
(day 4 post-infection ( p.i.)) by the Bioplex Protein Array system
[49] (Bio-Rad, Hercules, CA) using beads specific for mouse G-
CSF, IL-1a ,I L - 1 b, IL-3, IL-6, IL-9, IL-12 (p40), IL-12 (p70),
IL-13, Eotaxin, TNFa, RANTES, KC, MIP1-a,M I P - 1 b,M C P -
1, and IFN-c. Cytokine protein levels were measured according
to the manufacturers instructions by fluorescently conjugated
monoclonal antibodies in duplicate against a standard curve
(Figures 3 and 5).
Statistical analysis
Statistical significance of differences between experimental
groups was determined through the use of the unpaired, non-
parametric Student’s t test. Values of p,0.05 were considered
significant.
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